VOLITIONRX LTD
Company Information
Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1489 WEST WARM SPRINGS ROAD, HENDERSON, NV, 89014
Mailing Address 1489 WEST WARM SPRINGS ROAD, HENDERSON, NV, 89014
Phone 1 (512) 774-8930
Fiscal Year End 1231
EIN 911949078
Financial Overview
FY2024
-$7.80M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| DEF 14A Definitive proxy statement | February 11, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | February 9, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | February 3, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
| 4 Insider stock transaction report | January 23, 2026 | View on SEC |
Material Events
8-K Financial Distress February 9, 2026
High Impact
- VolitionRx develops novel blood-based diagnostic tests for serious diseases like cancer.
- Its Nu.Q® platform technology shows promise.
Related Companies
Companies in the same industry (SIC: 2835)
QuidelOrtho Corp
QDEL In Vitro & In Vivo Diagnostic Substances
IDEXX LABORATORIES INC /DE
IDXX In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX In Vitro & In Vivo Diagnostic Substances
NEOGEN CORP
NEOG In Vitro & In Vivo Diagnostic Substances
Intellia Therapeutics, Inc.
NTLA In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.